How clinical trials work: testing new treatments

What a clinical trial is

A clinical trial is a research study that tests a treatment in people to find out whether it is safe and whether it genuinely helps. Before any treatment reaches a trial, it goes through years of laboratory research to understand how it works and to check its safety as far as possible. A clinical trial is the crucial next step, because the only way to know for certain whether something helps patients — and what its side effects are — is to study it carefully in volunteers. Trials are not just for medicines; they also test vaccines, devices, operations, and even ways of preventing illness or organising care. The whole process is designed to answer clear questions reliably and safely, so that treatments shown to work can be offered widely and those that do not can be set aside.

The phases of a trial

New treatments usually pass through a series of phases, each answering a different question. Early first-in-human studies, sometimes called phase 1, test a treatment in a small number of people, focusing mainly on safety and how the body handles it. Phase 2 studies involve more people and look at whether the treatment seems to work and at side effects. Phase 3 trials are larger still, often comparing the new treatment against the current standard or a dummy treatment in many patients to confirm how well it works and how safe it is. Only after these steps can a treatment be considered for approval by regulators. After a treatment is in use, phase 4 studies continue to monitor its safety and effectiveness in everyday practice. Each phase builds on the last, and a treatment only moves forward if the evidence supports it.

How trials are made fair and reliable

Good trials use careful methods to make sure the results can be trusted. Many use randomisation, where a computer allocates volunteers by chance to receive either the new treatment or a comparison, so the groups are similar and the comparison is fair. Some use a placebo, a dummy treatment, to see whether the new treatment does better than no active treatment. Trials are often blinded, meaning the participants and sometimes the researchers do not know who is getting which treatment, which prevents expectations from skewing the results. These methods reduce bias and are why well-run trials are such powerful evidence. Results are analysed statistically to judge whether any benefit is real rather than chance, and findings are published so that others can scrutinise them and build on the knowledge.

How volunteers are protected

Protecting people who take part is central to how trials are run, and there are strong safeguards in the UK. Before a trial can start, it must be approved by an independent research ethics committee and by the medicines regulator, which check that it is scientifically sound and that risks to participants are minimised and justified. Everyone invited to take part goes through informed consent: they receive clear information about the trial, its possible benefits and risks, and what is involved, and they can ask questions and take time to decide. Taking part is always voluntary, and a participant can withdraw at any time without their normal care being affected. During the trial, participants are monitored closely, safety is watched continuously, and independent groups can stop a trial early if there are concerns. These layers of oversight aim to keep volunteers as safe as possible.

Taking part and why it matters

People take part in trials for different reasons: the chance to try a promising new treatment, closer monitoring of their health, or the wish to help others by advancing knowledge. In the UK, many trials run through the NHS, and a doctor or nurse may mention a suitable trial, or people can look into research opportunities themselves. It is important to weigh it up carefully: a new treatment may turn out to be better, no better, or occasionally worse than standard care, and there may be extra appointments or tests. Asking questions — about the aims, the possible risks and benefits, what is involved, and what happens afterwards — helps people decide. Whatever the result for an individual, taking part contributes to the evidence that improves care for everyone. Trials are the engine that turns promising ideas into treatments that truly help.